Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 25th June 2019
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Recall issued due to product defect
Particulates were found in some batches of Alfaxan and Alfaxan Multidose 10mg/ml Solution for Injection.

Specific batches of Alfaxan and Alfaxan Multidose affected

The Veterinary Medicines Directorate (VMD) is making vets and wholesalers aware that certain batches of Alfaxan and Alfaxan Multidose 10mg/ml Solution for Injection has been recalled.

Jurox UK issued a recall of specific batches after particulates were found during routine stability testing.

The manufacturer is contacting wholesalers and vets to urge them to examine their inventory immediately and quarantine any recalled products.

Affected batches are:

Batch No. Description Vm Number Pack Size Expiry
55523 Alfaxan Multidose 10 mg/ml Solution for injection for dogs, cats and pet rabbits Vm 25296/4004 10 ml 16/04/21
48317 Alfaxan 10 mg/ml Solution for injection for dogs, cats and pet rabbits Vm 25296/4003 10 ml 22/01/23
62816 Alfaxan 10 mg/ml Solution for injection for dogs, cats and pet rabbits Vm 25296/4003 10 ml 16/07/23

 

 

All other batches and the 20ml pack size are not affected by the recall.
For more information, contact Richard Beckwith on 07584 099536 or richard.beckwith@jurox.co.uk

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.